Luye Pharma Group Ltd. held its Annual General Meeting on 28 May 2025. During the meeting, several proposals were put forward and approved. Mr. HUANG Liming was re-elected as a non-executive Director, and Professor LO Yuk Lam was re-elected as an independent non-executive Director. Ms. XIA Lian was also re-elected as an independent non-executive Director. Additionally, Ernst & Young was re-appointed as the Auditor to hold office until the conclusion of the next annual general meeting of the Company.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.